-
Publication Venue For
-
Association Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical Outcomes..
7:934-944.
2022
-
Association of Transcatheter Aortic Valve Replacement Reimbursement, New Technology Add-on Payment, and Procedure Volumes With Embolic Protection Device Use..
7:945-952.
2022
-
Demographic and Regional Trends of Heart Failure-Related Mortality in Young Adults in the US, 1999-2019..
7:900-904.
2022
-
Evaluating the Application of Chronic Heart Failure Therapies and Developing Treatments in Individuals With Recent Myocardial Infarction: A Review.
2022
-
Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function..
7:825-835.
2022
-
External Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Randomized Clinical Trial..
7:808-816.
2022
-
Time to Revisit Using 10-Year Risk to Guide Statin Therapy..
7:785-786.
2022
-
Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial..
7:682-689.
2022
-
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review..
7:747-759.
2022
-
Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?-Reply..
7:657-658.
2022
-
Meaningful Evidence for Anticoagulation in the Gray (Elder) Zone..
7:581-582.
2022
-
Exercise and Resistant Hypertension-Is Exercise Enough?.
7:570-571.
2022
-
Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action From the Heart Failure Collaboratory..
7:540-548.
2022
-
Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content..
7:250-256.
2022
-
Differences in Cardiovascular Risk, Coronary Artery Disease, and Cardiac Events Between Black and White Individuals Enrolled in the PROMISE Trial..
7:259-267.
2022
-
Evaluation of Factors Underlying Sex-Based Disparities in Cardiovascular Care in Adults With Self-reported Premature Atherosclerotic Cardiovascular Disease..
7:341-345.
2022
-
Leadless Pacing-Uncertainties Remain About Safety and Efficacy-Reply..
7:361-362.
2022
-
Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial: A Secondary Analysis of a Randomized Clinical Trial..
7:140-148.
2022
-
Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis..
7:75-83.
2022
-
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial..
7:26-34.
2022
-
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial..
7:17-25.
2022
-
Identifying Treatments for Stage C2 Heart Failure..
7:34-35.
2022
-
Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US..
6:1415-1423.
2021
-
Extrapolating Survival From Randomized Clinical Trial Data-Possibilities and Caution..
6:1305-1307.
2021
-
Sex Differences in Procedural Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry..
6:1275-1284.
2021
-
Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker..
6:1187-1195.
2021
-
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination..
6:1196-1201.
2021
-
Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial..
6:1023-1031.
2021
-
Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry..
6:1078-1087.
2021
-
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial..
6:1032-1041.
2021
-
Competing Risks, Treatment Switching, and Informative Censoring..
6:871-873.
2021
-
Dapagliflozin-Does Cost Make 4-Pillar Heart Failure Therapy Too Herculean a Labor for Medicine?.
6:875-876.
2021
-
USPSTF Recommendations for Screening for Hypertension in Adults: It Is Time to Unmask Hypertensive Risk..
6:869-871.
2021
-
Association of Dual Eligibility for Medicare and Medicaid With Heart Failure Quality and Outcomes Among Get With The Guidelines-Heart Failure Hospitals..
6:791-800.
2021
-
Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease..
6:782-790.
2021
-
Simultaneous or Rapid Sequence Initiation of Quadruple Medical Therapy for Heart Failure-Optimizing Therapy With the Need for Speed..
6:743-744.
2021
-
Association of Posttraumatic Stress Disorder and Incident Ischemic Heart Disease in Women Veterans..
6:642-651.
2021
-
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial..
6:706-712.
2021
-
Incremental Benefits of Machine Learning-When Do We Need a Better Mousetrap?.
6:621-623.
2021
-
Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction..
6:522-531.
2021
-
Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model..
6:410-419.
2021
-
Assessing the Role of Rare Genetic Variation in Patients With Heart Failure..
6:379-386.
2021
-
Risk Stratification Science Goes to a New Level..
6:314-315.
2021
-
Antithrombotic Strategies in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention-Reply..
6:241.
2021
-
Incorporating Patient Preferences Into Hospital Quality Metrics for Heart Failure..
6:177-178.
2021
-
Organ Acceptance and Outcomes-A Surgeon's Perspective-Reply..
6:245-246.
2021
-
Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction..
6:68-77.
2021
-
Evaluation of Stress Cardiac Magnetic Resonance Imaging in Risk Reclassification of Patients With Suspected Coronary Artery Disease..
5:1401-1409.
2020
-
Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized With Heart Failure..
5:1349-1357.
2020
-
Should We Simplify Computed Tomography Angiography Reporting as Black or White vs Describing All Shades of Gray?-Reply..
5:1450-1451.
2020
-
Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) Registry.
2020
-
Influence of Clinical Trials of Acute Coronary Syndrome Beyond the Primary Hypothesis: A Systematic Review..
5:1286-1297.
2020
-
The Use of Sacubitril/Valsartan for Hospitalized Heart Failure-Why Do We Care About Cost and Value?.
5:1244.
2020
-
Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United States: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry..
5:1006-1010.
2020
-
Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19)..
5:988-990.
2020
-
Association Between Delays in Mechanical Ventilation Initiation and Mortality in Patients With Refractory Cardiogenic Shock..
5:965-967.
2020
-
Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals..
5:871-880.
2020
-
Functional vs Anatomical Testing for Patients With Stable Chest Pain-Binary or Directional Thinking?.
5:868-870.
2020
-
Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial..
5:757-764.
2020
-
Association Between Visit-to-Visit Blood Pressure Variability in Early Adulthood and Myocardial Structure and Function in Later Life..
5:795-801.
2020
-
Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial..
5:773-786.
2020
-
Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United States: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
2020
-
Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review..
5:714-722.
2020
-
Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure..
5:643-651.
2020
-
The Conundrum and Opportunity of Gender Equity for Evidence Generators..
5:623-624.
2020
-
Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist..
5:660-668.
2020
-
Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes..
5:703-708.
2020
-
Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19).
2020
-
Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS Trial..
5:532-539.
2020
-
Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation.
2020
-
Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis..
5:582-589.
2020
-
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial..
5:598-607.
2020
-
Association of Blood Pressure Patterns in Young Adulthood With Cardiovascular Disease and Mortality in Middle Age..
5:382-389.
2020
-
Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial..
5:411-419.
2020
-
Effects of a 9-Week Hybrid Comprehensive Telerehabilitation Program on Long-term Outcomes in Patients With Heart Failure: The Telerehabilitation in Heart Failure Patients (TELEREH-HF) Randomized Clinical Trial..
5:300-308.
2020
-
Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast Cancer..
5:309-317.
2020
-
Patient Perceptions and Familiarity With Medical Therapy for Heart Failure..
5:292-299.
2020
-
Age-Related Differences in the Noninvasive Evaluation for Possible Coronary Artery Disease: Insights From the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial..
5:193-201.
2020
-
Does Guideline-Directed Medical Therapy for Heart Failure Offer Benefits After LVAD Placement?-A Call for a Randomized Clinical Trial..
5:183.
2020
-
Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial..
5:202-207.
2020
-
Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older-Reply..
5:235-236.
2020
-
Temporal Trends in Racial Differences in 30-Day Readmission and Mortality Rates After Acute Myocardial Infarction Among Medicare Beneficiaries..
5:136-145.
2020
-
Translating the Secondary Prevention Therapeutic Boom Into Action..
5:215-216.
2020
-
Association of Pulmonary Hypertension With Clinical Outcomes of Transcatheter Mitral Valve Repair..
5:47-56.
2020
-
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial..
5:38-46.
2020
-
Clinical Considerations Prior to Transition From Triple Antithrombotic Therapy to Dual Antithrombotic Therapy-Reply..
5:111-112.
2020
-
Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review..
4:1287-1295.
2019
-
Logistical Challenges Associated With Implementing Precision Medicine-Reply..
4:1301.
2019
-
Population-Attributable Risk for Cardiovascular Disease Associated With Hypertension in Black Adults..
4:1194-1202.
2019
-
Patient and Hospital Characteristics of Mitral Valve Surgery in the United States..
4:1149-1155.
2019
-
Postoperative and Nonvalvular Atrial Fibrillation-Not So Different After All..
4:1147-1148.
2019
-
Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk..
4:969-977.
2019
-
Current Demographic Status of Cardiologists in the United States..
4:1029-1033.
2019
-
Association of Daytime and Nighttime Blood Pressure With Cardiovascular Disease Events Among African American Individuals..
4:910-917.
2019
-
Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial..
4:857-864.
2019
-
Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness..
4:928-935.
2019
-
Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial..
4:846-854.
2019
-
Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation..
4:756-764.
2019
-
Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials..
4:747-755.
2019
-
Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil: The BRIDGE Cardiovascular Prevention Cluster Randomized Clinical Trial..
4:408-417.
2019
-
Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States..
4:444-453.
2019
-
Evaluation of Mortality Data From the Social Security Administration Death Master File for Clinical Research..
4:375-379.
2019
-
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial..
4:273-286.
2019
-
Prognostic Value of Vasodilator Stress Cardiac Magnetic Resonance Imaging: A Multicenter Study With 48 000 Patient-Years of Follow-up..
4:256-264.
2019
-
What Is Needed Now to Improve Cardiovascular Clinical Registries in the Future..
4:201-202.
2019
-
Improving Value-Based Care for Left Ventricular Assist Device Therapy: Lowering Costs When Stakes Are High..
4:161-162.
2019
-
Omitted Potential Conflict of Interest Disclosures..
4:189.
2019
-
Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study..
4:51-58.
2019
-
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial..
4:7-15.
2019
-
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II..
3:1174-1182.
2018
-
Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry..
3:1151-1159.
2018
-
Electrocardiography Screening for Atrial Fibrillation: We Can Do Better..
3:1144-1145.
2018
-
Errors in Programming and Coding Affecting Cohorts Included in the Study Deriving and Validating the PROMISE Minimal-Risk Tool..
3:1253-1254.
2018
-
Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences..
3:1192-1199.
2018
-
Role Models, Allies, and Diversity-Global Issues for Female Cardiology Trainees-Reply..
3:1252.
2018
-
A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary Prevention..
3:1090-1095.
2018
-
Association Between Hospital Surgical Aortic Valve Replacement Volume and Transcatheter Aortic Valve Replacement Outcomes..
3:1070-1078.
2018
-
Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial..
3:1113-1118.
2018
-
Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals..
3:929-938.
2018
-
Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review..
3:1011-1019.
2018
-
Tools for Evaluating and Improving Causal Inference: Introducing JAMA Cardiology Readers to the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) Tool..
3:907.
2018
-
Trends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines-Heart Failure Registry..
3:917-926.
2018
-
Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy: A Phenome-Wide Association Study..
3:849-857.
2018
-
Finding Means to Fulfill the Societal and Academic Imperative for Open Data Access and Sharing..
3:793-794.
2018
-
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry..
3:739-748.
2018
-
Career Preferences and Perceptions of Cardiology Among US Internal Medicine Trainees: Factors Influencing Cardiology Career Choice..
3:682-691.
2018
-
Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Associated With Cardiac Channelopathies..
3:775-776.
2018
-
Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population..
3:583-590.
2018
-
Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review..
3:650-658.
2018
-
When Low-Risk Atrial Fibrillation Is Not So Low Risk: Beast of Burden..
3:558-560.
2018
-
Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines-Heart Failure Registry..
3:489-497.
2018
-
Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Related to Ischemic and Nonischemic Cardiomyopathy..
3:541-542.
2018
-
Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation..
3:417-424.
2018
-
The Burden of Cardiovascular Diseases Among US States, 1990-2016..
3:375-389.
2018
-
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial..
3:391-399.
2018
-
Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis..
3:234-241.
2018
-
Outpatient Worsening Heart Failure as a Target for Therapy: A Review..
3:252-259.
2018
-
Coronary Calcium Score and Cardiovascular Risk in Elderly Populations-Reply..
3:180-181.
2018
-
Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible Acute Coronary Syndrome..
3:104-111.
2018
-
Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial..
3:144-152.
2018
-
Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study..
3:54-63.
2018
-
Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure..
3:44-53.
2018
-
Association of Physical Activity With Risk of Major Cardiovascular Diseases in Chinese Men and Women..
2:1349-1358.
2017
-
Administrative Codes for Capturing In-Hospital Cardiac Arrest..
2:1275-1277.
2017
-
Association of Public Health Initiatives With Outcomes for Out-of-Hospital Cardiac Arrest at Home and in Public Locations..
2:1226-1235.
2017
-
Implantable Cardioverter Defibrillators for Nonischemic Cardiomyopathy-Reply..
2:1283-1284.
2017
-
Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial..
2:1197-1206.
2017
-
The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines..
2:1175-1176.
2017
-
When Should Patients Be Involved in Cardiovascular Clinical Trial Design?: Always, Early, and Often..
2:1269-1270.
2017
-
Association of Neighborhood Demographics With Out-of-Hospital Cardiac Arrest Treatment and Outcomes: Where You Live May Matter..
2:1110-1118.
2017
-
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy-Breakthrough in Low-Density Lipoprotein Cholesterol Lowering, Breakdown in Value..
2:1066-1068.
2017
-
SPECT, PET, and CTA-Acronyms or Better Imaging?.
2:1108-1109.
2017
-
Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies..
2:986-994.
2017
-
Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial..
2:950-958.
2017
-
Myocardial Fibrosis in Duchenne and Becker Muscular Dystrophy-Reply..
2:1046.
2017
-
Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice..
2:1040-1042.
2017
-
Outcomes Associated With Subcutaneous Implantable Cardioverter Defibrillators-Reply..
2:925-926.
2017
-
Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX Trial..
2:896-901.
2017
-
Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry..
2:846-854.
2017
-
Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study..
2:750-757.
2017
-
Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines..
2:723-731.
2017
-
Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial..
2:759-766.
2017
-
Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease..
2:635-643.
2017
-
Heterogeneity in Blood Pressure Transitions Over the Life Course: Age-Specific Emergence of Racial/Ethnic and Sex Disparities in the United States..
2:653-661.
2017
-
Integrating Research With Clinical Practice: Keeping It Simple..
2:616.
2017
-
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis..
2:685-688.
2017
-
Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study..
2:644-652.
2017
-
Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial..
2:525-534.
2017
-
Heart Failure With Reduced Ejection Fraction in Human Immunodeficiency Virus Infection: The More Things Stay the Same..
2:476-477.
2017
-
Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial..
2:547-555.
2017
-
Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study..
2:478-487.
2017
-
Value of Cardiovascular Magnetic Resonance Imaging-Derived Baseline Left Ventricular Ejection Fraction and Volumes for Precise Risk Stratification of Patients With Ischemic Cardiomyopathy: Insights From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial..
2:577-579.
2017
-
Assessing the Utility of Transcatheter Aortic Valve Replacement..
2:416-417.
2017
-
Identification of Patients With Stable Chest Pain Deriving Minimal Value From Noninvasive Testing: The PROMISE Minimal-Risk Tool, A Secondary Analysis of a Randomized Clinical Trial..
2:400-408.
2017
-
Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry..
2:409-416.
2017
-
Racial Differences in Associations of Blood Pressure Components in Young Adulthood With Incident Cardiovascular Disease by Middle Age: Coronary Artery Risk Development in Young Adults (CARDIA) Study..
2:381-389.
2017
-
Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy..
2:293-302.
2017
-
Ongoing Management of Patients With Supraventricular Tachycardia..
2:332-333.
2017
-
Quality of Evidence Underlying the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines on the Management of Atrial Fibrillation..
2:319-323.
2017
-
The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review..
2:324-331.
2017
-
Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program..
2:136-145.
2017
-
Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial..
2:190-199.
2017
-
Prediction of 30-Day All-Cause Readmissions in Patients Hospitalized for Heart Failure: Comparison of Machine Learning and Other Statistical Approaches..
2:204-209.
2017
-
Resting Heart Rate and Long-term Outcomes Among the African American Population: Insights From the Jackson Heart Study..
2:172-180.
2017
-
Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men-Reply..
2:108-110.
2017
-
Intensive Care Unit Utilization and Mortality Among Medicare Patients Hospitalized With Non-ST-Segment Elevation Myocardial Infarction..
2:36-44.
2017
-
Making Every Mobile Heart Count!.
2:78.
2017
-
Who Belongs in the Cardiac Intensive Care Unit?.
2:45-46.
2017
-
Do Not Over (P) Value Your Research Article..
1:1055.
2016
-
Risk Prediction With Electronic Health Records: The Importance of Model Validation and Clinical Context..
1:976-977.
2016
-
Understanding the Role of P Values and Hypothesis Tests in Clinical Research..
1:1048-1054.
2016
-
Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment..
1:864-871.
2016
-
Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less..
1:945-949.
2016
-
The US Food and Drug Administration and the Future of Cardiovascular Medicine..
1:950-952.
2016
-
Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States..
1:900-911.
2016
-
The Need to Improve Care and Research on Sexual Functioning in Cardiology..
1:765-766.
2016
-
Treatment, Outcomes, and Adherence to Medication Regimens Among Dual Medicare-Medicaid-Eligible Adults With Myocardial Infarction..
1:787-794.
2016
-
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial..
1:673-681.
2016
-
Comparing Inverse Probability of Treatment Weighting and Instrumental Variable Methods for the Evaluation of Adenosine Diphosphate Receptor Inhibitors After Percutaneous Coronary Intervention..
1:655-665.
2016
-
Population Effect of Differences in Cholesterol Guidelines in Eastern Europe and the United States..
1:700-707.
2016
-
Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure..
1:714-717.
2016
-
Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study..
1:548-556.
2016
-
Evaluation of Flow After Transcatheter Aortic Valve Replacement in Patients With Low-Flow Aortic Stenosis: A Secondary Analysis of the PARTNER Randomized Clinical Trial..
1:584-592.
2016
-
Acute Treatment of Patients With Supraventricular Tachycardia..
1:483-485.
2016
-
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical Trial..
1:451-460.
2016
-
Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals..
1:442-450.
2016
-
Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular Events..
1:492-494.
2016
-
Understanding the Adverse Effects of Ticagrelor in Practice..
1.
2016
-
Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry..
1:282-291.
2016
-
Gait Speed and Operative Mortality in Older Adults Following Cardiac Surgery..
1:314-321.
2016
-
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial..
1:126-135.
2016
-
Effect of the Presence and Type of Angina on Cardiovascular Events in Patients Without Known Coronary Artery Disease Referred for Elective Coronary Angiography..
1:232-234.
2016
-
The Enigma of Glucose and Lipid Metabolism..
1:145-146.
2016
-
Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction..
1:147-155.
2016
-
Using Data to Guide Anticoagulation in Patients With Atrial Fibrillation: Does the Analysis Fit the Question?.
1:121-122.
2016
-
Association Between Hospital Process Composite Performance and Patient Outcomes After In-Hospital Cardiac Arrest Care..
1:37-45.
2016
-
Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort..
1:15-25.
2016
-
Development and Validation of a Risk Prediction Model for In-Hospital Mortality After Transcatheter Aortic Valve Replacement..
1:46-52.
2016
-
Preventing Stroke in Patients With Atrial Fibrillation-A Steep Climb Away From Achieving Peak Performance..
1:63-64.
2016
-
Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome..
1:73-79.
2016
-
P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes.
2019